Neuberger Berman Group LLC Collegium Pharmaceutical, Inc Transaction History

Neuberger Berman Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$17.75 - $25.39 $1.84 Million - $2.64 Million	-103,933 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$21.74 - $25.28 $30,414 - $35,366	1,399 Added 1.36%	103,933 $2.45 Million
Q1 2021 May 13, 2021	BUY	$19.25 - $26.1 $29,529 - $40,037	1,534 Added 1.52%	102,534 $2.43 Million
Q2 2020 Aug 13, 2020	BUY	$15.49 - $23.51 $387,250 - $587,750	25,000 Added 32.89%	101,000 $1.77 Million
Q1 2020 May 14, 2020	BUY	$13.89 - $25.45 $1.06 Million - $1.93 Million	76,000 New	76,000 $1.24 Million

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.